Gitcoin / THE TICKER IS
0.00000013
21-December-24 10:12:46
realtime
Instruments
-1.03E-08
-7.11%
Today's range
0.00000013 - 0.00000013
ISIN
FXGTCETH
Source
GATE
-
New Fortress Energy (NASDAQ:NFE) Shares Gap Up on Analyst Upgrade
23 Dec 2024 09:36:12 By Buzz FX
-
Investors Buy High Volume of Amneal Pharmaceuticals Call Options (NASDAQ:AMRX)
23 Dec 2024 09:36:12 By Buzz FX
-
Traders Buy High Volume of Put Options on Equinix (NASDAQ:EQIX)
23 Dec 2024 09:36:12 By Buzz FX
-
Tempus AI (NASDAQ:TEM) Shares Down 5.7% Following Insider Selling
23 Dec 2024 09:36:12 By Buzz FX
-
ECB Plans to Clamp Down on Banks Ignoring Its Demands for Fixes
23 Dec 2024 09:31:12 By Buzz FX
-
Neurocrine Biosciences (NASDAQ:NBIX) Given "Overweight" Rating at Piper Sandler
23 Dec 2024 09:31:12 By Buzz FX
-
A federated digital dollar is key to sustaining US economic leadership
23 Dec 2024 09:20:24 By Buzz FX
-
23 Dec 2024 09:16:23 By Buzz FX
-
Enfusion (NYSE:ENFN) Reaches New 12-Month High After Analyst Upgrade
23 Dec 2024 09:16:11 By Buzz FX
-
Klaviyo (NYSE:KVYO) Sets New 1-Year High After Analyst Upgrade
23 Dec 2024 09:16:11 By Buzz FX
-
Piper Sandler Reaffirms Overweight Rating for Tamboran Resources (NYSE:TBN)
23 Dec 2024 09:01:12 By Buzz FX
-
Humacyte (NASDAQ:HUMA) Price Target Raised to $17.00 at Benchmark
23 Dec 2024 09:01:12 By Buzz FX
-
Loop Capital Lowers monday.com (NASDAQ:MNDY) Price Target to $300.00
23 Dec 2024 09:01:12 By Buzz FX
-
We're going back to 2019 level neutral rates, says Jefferies' David Zervos
23 Dec 2024 09:00:24 By Buzz FX
-
Canada’s GDP beats Oct expectations, but Nov decline looms
23 Dec 2024 08:41:12 By Buzz FX
-
US durable goods orders slump -1.1% mom, transportation sector leads decline
23 Dec 2024 08:41:12 By Buzz FX
-
Bank of America Initiates Coverage on Pony AI (NASDAQ:PONY)
23 Dec 2024 08:36:12 By Buzz FX
-
Snowflake (NYSE:SNOW) Price Target Raised to $205.00 at Loop Capital
23 Dec 2024 08:36:12 By Buzz FX
-
Benchmark Reiterates Buy Rating for Winnebago Industries (NYSE:WGO)
23 Dec 2024 08:36:12 By Buzz FX
-
Benchmark Reaffirms Buy Rating for Ligand Pharmaceuticals (NASDAQ:LGND)
23 Dec 2024 08:36:12 By Buzz FX